Manufacturing: Page 7
-
AstraZeneca broadens coronavirus vaccine manufacturing deal with Catalent
Catalent, which is already helping the British pharma make its vaccine, will now add key services from a Maryland gene therapy plant.
By Kristin Jensen • Aug. 26, 2020 -
Moderna
Moderna joins other vaccine leaders in European supply talks
The deal would designate up to 160 million doses of Moderna's shot for the European Union, which has worked aggressively of late to bolster its supply.
By Jonathan Gardner • Aug. 24, 2020 -
National Institute of Allergy and Infectious Diseases. (2020). "Novel coronavirus SARS-CoV-2" [Microscope image]. Retrieved from https://www.flickr.com/photos/nihgov/49535193876/in/album-72157713108522106/.
CureVac in talks to supply EU with coronavirus vaccine
A deal being negotiated would provide EU countries with 225 million doses of CureVac's experimental shot, which relies on similar technology as those developed by Moderna and BioNTech.
By Kristin Jensen • Aug. 20, 2020 -
Regeneron
Regeneron enlists Roche to boost production of COVID-19 antibody drug
Together, the companies expect they can make more than three times as many doses of Regeneron's antibody drug than the U.S. biotech could on its own.
By Kristin Jensen • Aug. 19, 2020 -
Europe, trailing US, UK, reaches first coronavirus vaccine deal
Both the U.S. and U.K. have aggressively signed preorder deals with vaccine developers. An agreement with AstraZeneca is the EU's first.
By Ned Pagliarulo • Aug. 14, 2020 -
National Institute of Allergy and Infectious Disease. (2020). "Novel Coronavirus SARS-CoV-2" [Image]. Retrieved from https://www.flickr.com/photos/nihgov/49655318098/in/album-72157713108522106/.
Argentina, Mexico line up to produce AstraZeneca, Oxford coronavirus vaccine
The manufacturing deal could help supply Latin America with Oxford's shot, which is one of the most advanced in clinical testing.
By Kristin Jensen • Aug. 13, 2020 -
Eastman Business Park/Courtesy of Eastman Kodak Company
US puts Kodak loan on hold after stock scrutiny
Lawmakers questioned the timing of stock options granted to Kodak executives a day before the planned $765 million loan was announced. An SEC investigation is reportedly underway.
By Ned Pagliarulo • Aug. 10, 2020 -
Permission granted by Gilead Sciences
Pfizer to help Gilead produce COVID-19 drug remdesivir
With supplies of the in-demand drug tight, Gilead has enlisted Pfizer, along with companies across the globe, to churn out millions of treatment courses.
By Ned Pagliarulo • Aug. 7, 2020 -
Getty Images
Trump tries to revamp drug supply chain with latest order
A directive announced by the president would require government agencies to buy certain "essential" drugs from factories in the U.S. How easily such an order would be implemented isn't clear.
By Ben Fidler • Aug. 6, 2020 -
National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Image]. Retrieved from https://www.flickr.com/photos/nihgov/49565892277/in/album-72157713108522106/.
India's role in coronavirus vaccine manufacturing grows with new deals
The Serum Institute, one of the world's largest vaccine producers, licensed Novavax's experimental shot, while Wockhardt signed on with the U.K. to help make AstraZeneca's candidate.
By Kristin Jensen • Aug. 6, 2020 -
Courtesy of FujiFilm
US taps camera makers for help manufacturing drugs, vaccines
The Trump administration plans to loan Kodak $765 million to produce drug ingredients, one day after enlisting Fujifilm to help make coronavirus vaccines.
By Ned Pagliarulo • July 28, 2020 -
Retrieved from Sandoz on July 27, 2020
Sandoz earmarks $175M to upgrade tech at European hub for antibiotics manufacturing
About a third of the money will come from the Austrian government and be put toward technology used to make the active ingredients in penicillin products.
By Jacob Bell • July 27, 2020 -
National Institute of Allergy and Infectious Diseases. (2020). "Novel Coronavirus SARS-CoV-2" [Image]. Retrieved from https://www.flickr.com/photos/nihgov/49565892277/in/album-72157713108522106/.
UK to spend almost $130M more on coronavirus vaccine manufacturing
The investment will upgrade a Cell and Gene Therapy Catapult site so it can manufacture coronavirus vaccines and respond to future pandemics.
By Jacob Bell • July 23, 2020 -
Thermo Fisher rakes in $1.3B in coronavirus-related revenue
The second quarter saw the company's diagnostic and healthcare end market sales jump more than 70% due to soaring demand for COVID-19 testing.
By Nick Paul Taylor • July 22, 2020 -
Courtesy of https://ventecgm.com/
An insider's look at how GM, Ventec ramped up ventilator production amid COVID-19
The weight of the Defense Production Act helped open doors, said the CEO of the engineering firm contracted to test each of the 30,000 devices expected under the agreement.
By Greg Slabodkin • July 13, 2020 -
Novartis
Civica enlists Novartis to produce generic injectable drugs
Founded by hospital systems to address drug shortages, the nonprofit group has now struck several partnerships to expand its network of suppliers.
By Kristin Jensen • July 9, 2020 -
Regeneron
US buys up early supply of Regeneron's COVID-19 antibody cocktail
A $450 million grant will help Regeneron scale up manufacturing of its drug, which is among the front-running antibody therapies for COVID-19.
By Jonathan Gardner • July 7, 2020 -
Courtesy of Novavax, Australian Broadcasting Corporation
Novavax gets $1.6B in US funding for coronavirus vaccine
The funding will secure 100 million doses of Novavax's experimental shot, which is set to begin late-stage testing this fall.
By Ned Pagliarulo • July 7, 2020 -
Janssen
J&J, with new deal, plans for long-term manufacture of coronavirus vaccine
A five-year agreement with Maryland's Emergent Biosolutions will provide for large-scale production of J&J's candidate, set to begin testing in July.
By Ned Pagliarulo • July 6, 2020 -
Jacob Bell
Novartis cancer drug unit to build Indianapolis factory
Advanced Accelerator Applications, a subsidiary of the Swiss pharma, will build a new site to produce targeted radioligand therapies like Lutathera.
By Kristin Jensen • July 2, 2020 -
Permission granted by BioNTech SE
WHO lays out ambitious plan to deliver 2 billion coronavirus vaccine doses
More than $18 billion will be needed for the WHO's plan, which would secure and allocate vaccine supplies for high-risk groups and lower-income countries.
By Ned Pagliarulo • June 26, 2020 -
Moderna
Moderna adds Catalent as vaccine manufacturing partner
Catalent will help with some of the final manufacturing steps for the biotech's experimental coronavirus vaccine, set to begin late-stage testing next month.
By Kristin Jensen • June 25, 2020 -
National Institute of Allergy and Infectious Diseases. (2020). "Novel coronavirus SARS-CoV-2" [Microscope image]. Retrieved from https://www.flickr.com/photos/nihgov/49535193876/in/album-72157713108522106/.
Inovio gets U.S. government backing for vaccine delivery device
The contract from the U.S. Department of Defense will help Inovio scale up production of its coronavirus vaccine, which, unlike many rivals, relies on an electroporation device.
By Kristin Jensen • June 24, 2020 -
Courtesy of Lonza
Deep DiveVaccines can end the coronavirus pandemic. Will every country get them?
Scientists around the world are racing to develop a coronavirus vaccine. But the factories slated to make the leading candidates are concentrated in a handful of countries, raising concerns about global access.
By Jonathan Gardner • June 23, 2020 -
Craighead, Shealah. (2020). "President Trump Delivers an Update on Vaccine Development" [Photograph]. Retrieved from Flickr.
'Warp Speed' plan for coronavirus vaccines comes into focus
Developers backed by the project will get preferential access to manufacturing and distribution capacity secured by the U.S. government.
By Ned Pagliarulo • June 17, 2020
Previous
